Primary biliary cholangitis (PBC) is a chronic progressive autoimmune disorder characterized by small non-purulent ...

Update on regulatory strategy for govorestat for the treatment of CMT-SORD following receipt of Type C meeting minutes– Meeting scheduled ...

Aardvark has aligned with the FDA to reduce the minimum age of eligibility from 13 to 10 years old for pediatric patients in HERO, the Phase 3 ...

Lantern Pharma will host a conference call and webcast to discuss third quarter 2025 financial results and business updates on Thursday, November 13, 2025 at 9:00 a.m. Eastern Time.

Aardvark has aligned with the FDA to reduce the minimum age of eligibility from 13 to 10 years old for pediatric patients in HERO, the Phase 3 trial of ARD-101 for the treatment of hyperphagia associa ...

Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.

Immunometabolism have advanced the understanding of dynamic interplay between metabolic pathways and immune responses.

BBOT debuted as a publicly traded company focused on optimized target coverage for patients with tumors driven by RAS and ...

Weill Cornell Medicine investigators have identified an early step in a cellular process that leads to inflammation in fat ...

Throughout evolution, pathogenic microorganisms, such as bacteria, viruses, and fungi, have developed sophisticated defense ...

Esperion Therapeutics stock remains a buy as strong drug franchises, growth, and global milestones outweigh risks. Learn more ...